Ad Lentus GmbH

Ad Lentus GmbH, a German limited liability company, provides specific analytical laboratory services focusing on the isolation and analysis of various human cell types and cytokines while developing somatic therapeutic research products; it is headquartered in Germany.

Here are key aspects of the company:

• Products & Services: The firm offers comprehensive consulting and execution for process optimization, process development, biotechnology production readiness from bench to bedside, and GMP compliance within the pharmaceutical and biotechnology sectors.
• Industries: Their core competencies span regenerative medicine, anti-inflammatory treatments, oncology applications, and therapies for autoimmune diseases through personalized medicine approaches.
• Innovation: The company is currently developing a cell-based Advanced Therapy Medical Product (ATMP) specifically designed for onkological use based on years of accumulated experience.

Ad Lentus GmbH combines specialized analytical capabilities with advanced research and development to deliver innovative, tailored therapeutic solutions that meet the latest scientific and technological standards.